Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury

Urology

Volumn 62, Issue 4, 2003, Pages 750-754

  Inman, Sharon R ^a,b   Davis, Nancy A ^a   Olson, Kristen M ^a   Lukaszek, Victoria A ^a   McKinley, Marc R ^a   Seminerio, Jennifer L ^a  

^a OHIO UNIVERSITY   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; FEEDING; GLOMERULUS FILTRATION; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0141449212     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00475-8     Document Type: Article

References (19)

1. Olyaei A.J., de Mattos A.M., Bennett W.M. Immunosuppressant-induced nephropathy. Drug Safety. 21:1999;471-488.
2. Dumont F.J., Su Q. Mechanism of action of the immunosuppressant rapamycin. Life Sci. 58:1996;373-395.
3. Sacks S.H. Rapamycin on trial. Nephrol Dial Transplant. 14:1999;2087-2089.
4. Inman S.R., Burns T.E., Plott W.K., et al. Endothelin receptor blockade during hypothermic perfusion preservation mitigates the adverse effect of pre-retrieval warm ischemic injury on post-transplant glomerular filtration rate. Transplantation. 74:2002;164-168.
5. Lewis R.M., Kerr N., Van Buren C.T., et al. Comparative evaluation of urographic contrast media, inulin, and 99m Tc-DPTA clearance methods for determination of glomerular filtration rate in clinical transplantation. Transplantation. 48:1989;790-796.
6. Tofovic S.P., Kost C.K. Jr, Jackson E.K., et al. Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-fa (cp)) rats. Kidney Int. 61:2002;1433-1444.
7. Lowry O.H., Rosebrough N.J., Fall A.L., et al. Protein measurement with the oflin phenol reagent. J Biol Chem. 193:1951;265-275.
8. Zar JH: Multicentral hypothesis: the analysis of variance, in Biostatistical Analysis, 2nd ed. Englewood Cliffs, NJ, Prentice-Hall, 1984, p 164.
9. Prado R.A., Toledo-Pereyra L.H., Lentsch A.B., et al. Ischemia/reperfusion injury research review . J Surg Res. 105:2002;248-258.
10. Dumont F.J., Su Q. Mechanism of action of the immunosuppressant rapamycin. Life Sci. 58:1996;373-395.
11. Vanrenterghem Y.F.C. Tailoring immunosuppressant therapy for renal transplant recipients. Pediatr Transplantation. 5:2001;467-472.
12. Shihab F.S. Cyclosporine nephropathy pathophysiology and clinical impact . Semin Nephrol. 16:1996;536-547.
13. Whiting P.H., Woo J., Adam B.J., et al. Toxicity of rapamycin - a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat. Transplantation. 52:1991;203-208.
14. Golbaekdal K., Nielsen C.B., Djurhuus J.C., et al. Effects of rapamycin on renal hemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide and vasopressin in pigs. Transplantation. 58:1994;1153-1157.
15. Kanazi G., Stowe N., Steinmuller D., et al. Effect of cyclosporine upon the function of ischemically damaged kidneys in the rat. Transplantation. 41:1986;782-784.
16. Hong J.C., Kahan B.D. Immunosuppressive agents in organ transplantation past, present and future . Semin Nephrol. 20:2000;108-125.
17. Bennett W.M. Mechanisms of acute and chronic nephrotoxicity from immunosuppressant drugs. Renal Failure. 18:1996;453-460.
18. Saunders R.N., Metcalfe M.S., Nicholson M.L. Rapamycin in transplantation a review of the evidence . Kidney Int. 59:2001;3-16.
19. Johnson R.W.G., Kreis H., Oberbauer R., et al. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation. 72:2001;777-786.